{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:38:57Z","timestamp":1770781137828,"version":"3.50.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1038\/nm0897-887","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T02:11:34Z","timestamp":1092881494000},"page":"887-893","source":"Crossref","is-referenced-by-count":230,"title":["Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth"],"prefix":"10.1038","volume":"3","author":[{"given":"Yiping","family":"Wang","sequence":"first","affiliation":[]},{"given":"Dorothea","family":"Becker","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0897887_CR1","first-page":"250","volume-title":"Biologic Therapy of Cancer","author":"PM Marincola","year":"1995","unstructured":"Marincola, P.M. & Rosenberg, S.A. Biologic therapy with interleukin-2: Preclinical studies. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 250\u2013262 (Lippincott, Philadelphia, 1995)."},{"key":"BFnm0897887_CR2","first-page":"388","volume-title":"Biologic Therapy of Cancer","author":"JM Kirkwood","year":"1995","unstructured":"Kirkwood, J.M. Biologic therapy with interferon-\u03b1 and \u03b2: Clinical applications. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 388\u2013411 (Lippincott, Philadelphia, 1995)."},{"key":"BFnm0897887_CR3","first-page":"576","volume-title":"Biologic Therapy of Cancer","author":"AN Houghton","year":"1995","unstructured":"Houghton, A.N. & Chapman, P.B. Clinical applications of monoclonal antibodies in cancer. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 576\u2013590 (Lippincott, Philadelphia, 1995)."},{"key":"BFnm0897887_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P Van Der Bruggen","year":"1991","unstructured":"Van Der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643\u20131647 (1991).","journal-title":"Science"},{"key":"BFnm0897887_CR5","first-page":"177","volume":"3","author":"R Halaban","year":"1988","unstructured":"Halaban, R., Kwon, B.S., Ghosh, S., Delli-Bovi, P. & Baird, A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3, 177\u2013186 (1988).","journal-title":"Oncogene Res."},{"key":"BFnm0897887_CR6","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1002\/j.1460-2075.1989.tb08543.x","volume":"8","author":"D Becker","year":"1989","unstructured":"Becker, D., Meier, C.B. & Herlyn, M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J. 8, 3685\u20133691 (1989).","journal-title":"EMBO J."},{"key":"BFnm0897887_CR7","first-page":"2302","volume":"7","author":"D Becker","year":"1992","unstructured":"Becker, D., Lee, P.L., Rodeck, U. & Herlyn, M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7, 2302\u20132313 (1992).","journal-title":"Oncogene"},{"key":"BFnm0897887_CR8","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/j.1460-2075.1986.tb04530.x","volume":"5","author":"JA Abraham","year":"1986","unstructured":"Abraham, J.A. et al. Human basic fibroblast growth factor: Nucleotide sequence and genomic organization. EMBO J. 5, 2523\u20132528 (1986).","journal-title":"EMBO J."},{"key":"BFnm0897887_CR9","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1128\/MCB.10.9.4728","volume":"10","author":"DE Johnson","year":"1990","unstructured":"Johnson, D.E., Lee, P.L., Lu, J. & Williams, L.T. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728\u20134739 (1990).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm0897887_CR10","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1128\/MCB.11.9.4627","volume":"11","author":"DE Johnson","year":"1991","unstructured":"Johnson, D.E., Lu, J., Chen, S., Werner, S. & Williams, L.T. The human fibroblast growth factor genes: A common structural arrangement underlies the mechanism for generating receptors that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627\u20134634 (1991).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm0897887_CR11","first-page":"637","volume":"2","author":"J Vignovich","year":"1993","unstructured":"Vignovich, J. & Becker, D. Expression of bFGF and differential expression of FGF receptors in normal human myoblasts and rhabdomyosarcomas. Int. J. Oncol. 2, 637\u2013642 (1993).","journal-title":"Int. J. Oncol."},{"key":"BFnm0897887_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0006-291X(91)91366-K","volume":"179","author":"X Gao","year":"1991","unstructured":"Gao, X. & Huang, L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280\u2013285 (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm0897887_CR13","first-page":"542","volume":"3","author":"J-P Yang","year":"1996","unstructured":"Yang, J.-P. & Huang, L. Direct gene transfer to mouse melanoma by intratumor injection of free DMA. Gene Ther. 3, 542\u2013547 (1996).","journal-title":"Gene Ther."},{"key":"BFnm0897887_CR14","doi-asserted-by":"publisher","first-page":"11307","DOI":"10.1073\/pnas.90.23.11307","volume":"90","author":"GJ Nabel","year":"1993","unstructured":"Nabel, G.J. et al. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307\u201311311 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897887_CR15","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/j.1460-2075.1993.tb05924.x","volume":"12","author":"S Werner","year":"1993","unstructured":"Werner, S. et al. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J. 12, 2635\u20132643 (1993).","journal-title":"EMBO J."},{"key":"BFnm0897887_CR16","first-page":"752","volume":"43","author":"RJ Nickoloff","year":"1993","unstructured":"Nickoloff, R.J. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. J. Clin. Pathol. 43, 752\u2013757 (1993).","journal-title":"J. Clin. Pathol."},{"key":"BFnm0897887_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00437598","volume":"391","author":"M Sehested","year":"1981","unstructured":"Sehested, M. & Hou-Jensen, K. Factor VIII-related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch. 391, 217\u2013225 (1981).","journal-title":"Virchows Arch."},{"key":"BFnm0897887_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-065X.1979.tb00289.x","volume":"47","author":"JA Ledbetter","year":"1979","unstructured":"Ledbetter, J.A. & Herzenberg, L.A. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63\u201367 (1979).","journal-title":"Immunol. Rev."},{"key":"BFnm0897887_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0014-4827(88)90271-6","volume":"179","author":"M Herlyn","year":"1988","unstructured":"Herlyn, M., Mancianti, M.L., Jambrosic, J., Bolen, J.B. & Koprowski, H. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp. Cell Res. 179, 322\u2013331 (1988).","journal-title":"Exp. Cell Res."},{"key":"BFnm0897887_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/1523-1747.ep12477822","volume":"97","author":"U Rodeck","year":"1991","unstructured":"Rodeck, U. et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Invest. Dermatol. 97, 20\u201326 (1991).","journal-title":"J. Invest. Dermatol."},{"key":"BFnm0897887_CR21","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1002\/j.1460-2075.1990.tb07454.x","volume":"9","author":"CA Dionne","year":"1990","unstructured":"Dionne, C.A. et al. Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685\u20132692 (1990).","journal-title":"EMBO J."},{"key":"BFnm0897887_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1073\/pnas.88.4.1095","volume":"88","author":"K Keegan","year":"1991","unstructured":"Keegan, K., Johnson, D.E., Williams, L.T. & Hayman, M.J. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88, 1095\u20131099 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897887_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/j.1460-2075.1991.tb07654.x","volume":"10","author":"J Partanen","year":"1991","unstructured":"Partanen, J. et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347\u20131354 (1991).","journal-title":"EMBO J."},{"key":"BFnm0897887_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jcb.240470305","volume":"47","author":"N Ferrara","year":"1991","unstructured":"Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, J. & Leung, D.W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211\u2013218 (1991).","journal-title":"J. Cell. Biochem."},{"key":"BFnm0897887_CR25","first-page":"206","volume-title":"The Molecular Basis of Cancer","author":"J Folkman","year":"1995","unstructured":"Folkman, J. Tumor angiogenesis. in: The Molecular Basis of Cancer. (eds. Mendelsohn, J., Howley, P.M., M., Israel, M.A. & Liotta, LA.) 206\u2013232 (Saunders, Philadelphia, 1995)."},{"key":"BFnm0897887_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353\u2013364 (1996).","journal-title":"Cell"},{"key":"BFnm0897887_CR27","first-page":"1733","volume":"7","author":"Y Wang","year":"1996","unstructured":"Wang, Y. et al. Molecular analysis of melanoma precursor lesions. Cell Growth Differ. 7, 1733\u20131740 (1996).","journal-title":"Cell Growth Differ."},{"key":"BFnm0897887_CR28","first-page":"18","volume":"10","author":"DE Elder","year":"1993","unstructured":"Elder, D.E., Clark, W.H., Jr., Glenitsas, R., Guerry, D., IV & Halpern, A.C. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi. Semin. Diagn. Pathol. 10, 18\u201335 (1993).","journal-title":"Semin. Diagn. Pathol."},{"key":"BFnm0897887_CR29","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1073\/pnas.93.5.2002","volume":"93","author":"S Parangi","year":"1996","unstructured":"Parangi, S. et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA 93, 2002\u20132007 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897887_CR30","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1073\/pnas.92.10.4562","volume":"92","author":"RK Singh","year":"1995","unstructured":"Singh, R.K. et al. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA 92, 4562\u20134566 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897887_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.7512751","volume":"264","author":"PC Brooks","year":"1994","unstructured":"Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin \u03b1\u03c5\u03b23 for angiogenesis. Science 264, 569\u201357 (1994).","journal-title":"Science"},{"key":"BFnm0897887_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"PC Brooks","year":"1994","unstructured":"Brooks, P.C. et al. Integrin \u03b1\u03c5\u03b23 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157\u20131164 (1994).","journal-title":"Cell"},{"key":"BFnm0897887_CR33","doi-asserted-by":"publisher","first-page":"8856","DOI":"10.1073\/pnas.91.19.8856","volume":"91","author":"AMP Montgomery","year":"1994","unstructured":"Montgomery, A.M.P., Reisfeld, R.A. & Cheresh, D.A. Integrin \u03b1\u03c5\u03b23 rescues melanoma cells from apoptosis in a three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA 91, 8856\u20138860 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897887_CR34","first-page":"461","volume":"56","author":"M Herlyn","year":"1987","unstructured":"Herlyn, M. et al. Biology of tumor progression in human melanocytes. Lab. Invest. 56, 461\u2013474 (1987).","journal-title":"Lab. Invest."},{"key":"BFnm0897887_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm0595-453","volume":"1","author":"KJ Walgenbach","year":"1995","unstructured":"Walgenbach, K.J., Gratas, C., Shestak, K.C. & Becker, D. Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nature Med. 1, 453\u2013459 (1995).","journal-title":"Nature Med."},{"key":"BFnm0897887_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/286400a0","volume":"286","author":"E Gaynor","year":"1980","unstructured":"Gaynor, E., Irie, R., Morton, D. & Herschman, H.R. S100 protein is present in cultured human malignant melanomas. Nature 286, 400\u2013401 (1980).","journal-title":"Nature"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0897-887","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0897-887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0897-887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:31:07Z","timestamp":1684452667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0897-887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["BFnm0897887"],"URL":"https:\/\/doi.org\/10.1038\/nm0897-887","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}